Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Chen Bihua reported a 11.80% stake in Blossomhill Therapeutics, Inc. (Schedule 13D)
Event Aug 6, 2026 · Filed Aug 13, 2026
Chen Bihua reported a 11.80% stake in Blossomhill Therapeutics, Inc., 3,615,362 shares, with active intent on Aug 6, 2026. Filed Aug 13, 2026 (Schedule 13D).
- Stake
- 11.80%
- Shares
- 3,615,362
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cormorant Global Healthcare Master Fund, LP | 3.13% | 959,090 |
| Cormorant Global Healthcare GP, LLC | 3.13% | 959,090 |
| Cormorant Private Healthcare Fund III, LP | 4.01% | 1,228,315 |
| Cormorant Private Healthcare GP III, LLC | 4.01% | 1,228,315 |
| Cormorant Private Healthcare Fund V, LP | 3.43% | 1,052,460 |
| Cormorant Private Healthcare GP V, LLC | 3.43% | 1,052,460 |
| Cormorant Private Healthcare Fund VI, LP | 1.22% | 374,169 |
| Cormorant Private Healthcare GP VI, LLC | 1.22% | 374,169 |
| Cormorant Asset Management, LP | 11.79% | 3,614,034 |
| Chen Bihua | 11.80% | 3,615,362 |
Source
Related
- Blossomhill Therapeutics, Inc.
- Chen Bihua
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026
- Form 4 · OrbiMed Capital GP VIII LLC · Aug 12, 2026